Adastra Labs receives Health Canada approval to Include cocaine under Controlled Substances Dealer’s License
LANGLEY – Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP), a leading cannabis company focused on processing, adult-use and medical sales, organoleptic testing and analytical testing,announced that Adastra Labs received approval from Health Canada on February 17, 2023, for its amendment to include cocaine as a substance that the Company can legally possess, produce, sell and distribute. The Company received its...
Read More
